97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00616434 (ClinicalTrials.gov)	May 2008	5/2/2008	A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Avonex® in Subjects With Moderate to Severe Ulcerative Colitis	Active Ulcerative Colitis	Drug: BG9418 (Interferon beta-1a);Drug: Placebo	Biogen	NULL	Completed	18 Years	65 Years	All	123	Phase 2	United States;Canada;Czech Republic;Hungary;Poland;Russian Federation;Slovakia
2	NCT00048347 (ClinicalTrials.gov)	October 2002	29/10/2002	Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis	An Open-Label, Pilot Study of Type I Interferon (AVONEX) Treatment of Ulcerative Colitis	Ulcerative Colitis	Drug: AVONEX	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Completed	18 Years	N/A	All	18	Phase 2	United States
3	NCT00303381 (ClinicalTrials.gov)	December 2001	14/3/2006	Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative Colitis	A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose-finding Phase II Study of Subcutaneously Administered IFN-beta-1a in the Treatment of Patients With Moderately Active Ulcerative Colitis	Ulcerative Colitis	Drug: Interferon-beta -1a , 44 microgram;Drug: Placebo;Drug: Interferon-beta -1a , 66 microgram	EMD Serono	Merck Serono International SA	Completed	18 Years	N/A	Both	194	Phase 2	Germany;Israel;Netherlands;Singapore;Sweden;Switzerland;United Kingdom;Spain